Twenty Chinese medicines are great! 9 exclusive Chinese medicine bright eye 6 billion varieties lead

The latest data forecast that in 2020, China's urban retail pharmacy terminal sales of Chinese medicine is expected to reach 105.4 billion yuan, the first negative growth of the market, respiratory diseases drug market leader.
chinese medicine has played an important role in the prevention and control of the new crown pneumonia epidemic, the impact of the outbreak on its market is not small.
products TOP20, 11 varieties of sales of more than 1 billion yuan, A gum sales of 5,995 million yuan far ahead, the exclusive Chinese medicine has 9;
105.4 billion! In recent years, the retail market or negative growth of Chinese medicine has continued to slow down in the retail pharmacy market.
chinese medicine has played an important role in the prevention and control of the new crown pneumonia epidemic, its development is facing more and more challenges.
meters of intranet data forecast that in 2020 China's urban retail pharmacy terminal sales of Chinese medicine is expected to reach 105.4 billion yuan, down 5.5% year-on-year, the first decline in nearly five years.
China's urban retail pharmacy terminal sales of Chinese medicine (units: 100 million yuan) Source: Minet China's urban retail pharmacies, Chinese medicine terminal competition pattern from the pattern of chinese medicine, respiratory disease medication is the most retail pharmacies The best-selling categories, accounting for 26.28% of the market share, digestive disease drugs, cardiovascular disease drugs, rehydration of blood drugs ranked second, third, fourth, market share of more than 10%.
2020 China's urban retail pharmacy terminal chinese medicine pattern forecast source: Mi net China's urban retail pharmacy Chinese medicine terminal competition pattern in the traditional drug manufacturer TOP20, dong gum's leading position is still difficult to shake, China Resources 39 Pharmaceuticals, Taiji Group Chongqing Lingling Pharmaceuticals, Yunnan White Pharmaceutical Group, Shandong Fu brand A gum are ranked TOP5, sales are more than 2 billion yuan.
, Shandong Fu brand A gum, Shijiazhuang Toling Pharmaceuticals, Yangzijiang Pharmaceutical Group 3 pharmaceutical companies sales growth is strong.
China's urban retail pharmacy terminal Chinese medicine manufacturer TOP20 Source: Mi Net China's urban retail pharmacy Chinese medicine terminal competition pattern of Chinese medicine TOP20 out! 11 more than 1 billion varieties of Chinese urban retail pharmacy terminal Chinese medicine products TOP20 Source: MiNet China's urban retail pharmacies Chinese medicine terminal competition pattern Minet data forecast, 2020 China's urban retail pharmacy terminal Chinese medicine products TOP20, 11 varieties of sales of more than 1 billion yuan, even flowering plague capsules, double yellow oral liquid, plate blue root particles are listed.
cold medicine has 4 products on the list, blood supplements have 3 products on the list, intestinal medication, coughing sputum flat wheezing drugs have 2 products on the list.
A gum led the way with sales of 5,995 million yuan, but the market declined, led by sales of Lianhua Qing plague capsules with 108.06 percent growth, and sales of compound A gum pulp fell 40.75 percent.
9 of the 20 products are exclusive varieties, respectively, Lianhua Qing plague capsules, Kyoto Nessi honey-refined Sichuan mussel paste, blue statin oral solution, shu-jiang waist pills, tablets , enteritis ning tablets, Yining pills, emergency syrup, compound a gum.
it is worth mentioning that, in addition to lianhua qing plague capsules, blue herring oral liquid and chip , sales of other exclusive varieties are negative growth.
oral solution is the exclusive variety of Yangzijiang Pharmaceutical Group, leading the throat of chinese medicine retail market.
tabletis the main product ofpharmaceutical industry, leading the hepatitis Chinese medicine market.
lianhua qing plague capsule is the exclusive variety of Ling Pharmaceuticals, approved in April 2020 for routine treatment of new crown pneumonia, sales to achieve strong growth.
China Resources bully screen! Tai Chi, Baiyunshan, Fukuo A gum... On the list of China's urban retail pharmacy terminal Chinese medicine brand TOP20 source: Minet China's urban retail pharmacy Chinese medicine terminal competition pattern MiNet data forecast that in 2020, China's urban retail pharmacy terminal Chinese medicine brand TOP20, 9 brands sales of more than 1 billion yuan, sales of more than 3 billion yuan, 2 billion yuan of brands each have one, respectively, Dong'a gum A gum, Huarun 39 pharmaceutical particles.
China Resources Pharmaceutical Company has a total of 4 brands on the list, respectively, A gum, cold spirit particles, stomach-churning tablets and compound a glue.
, sales of A gum and compound A-pulp declined more significantly, while sales of gastric eclipse tablets are expected to grow by 4.15%.
A gum, Taiji Group, Baiyunshan have 2 brands on the list.
among them, the sales of plate blue root particles in Baiyunshan increased by 36.26% YoY, the sales of A gum rehydration oral fluid and A gum increased by 45.16% and 26.88% YoY, respectively, and the sales of fennel positive gas oral liquid of Taiji Group increased by 7.61% YoY, leading the retail pharmacy intestinal medicine market.
data source: Minet China's urban retail pharmacies, Chinese medicine terminal competition pattern